We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

17 hedge funds and large institutions have $429K invested in GeneDx Holdings Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more capital invested

Capital invested by funds: $151K → $429K (+$278K)

2.25% more ownership

Funds ownership: 7.5%9.75% (+2.3%)

0% more funds holding

Funds holding: 1717 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
3
Calls
$34K
Puts
Net Calls
+$34K
Net Calls Change
-$122K

WGSWW Hedge Fund Activity: Q4 2024 in Review

17 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q4 2024, worth a combined $429K — up 184% from $151K a quarter earlier.

Fund positioning in WGSWW was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $264K. The largest seller was GTS Securities, exiting entirely with an estimated $4.19K sold.

  • 17 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $429K of GeneDx Holdings Warrant stock for Q4 2024, up 184% quarter-over-quarter.
  • 3 funds opened new GeneDx Holdings Warrant positions in Q4 2024 and 3 closed out, a net change of 0 holders.
  • The largest GeneDx Holdings Warrant buyer in Q4 2024 was LMR Partners, an estimated $264K added.
  • The largest GeneDx Holdings Warrant seller in Q4 2024 was GTS Securities, an estimated $4.19K sold.

Based on aggregated 13F filings for Q4 2024.